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Multidrug resistant Staphylococcus aureus poses a severe global threat worldwide 
due to their prevalence, genomic plasticity and limited therapeutic options being 
refractory to most antibiotic classes. This necessitates the discovery of new anti-
staphylococcal interventions. Callistemon rigidus R.Br. (Myrtaceae) has been found 
to possess antibacterial potential against clinical isolates. Thied me study was a isolate 
and evaluate the antibacterial alkaloids from the leaves of Callistemon rigidus and 
assess their in vitro anti-staphylococcal potential. Alkaloid isolation was carried out 
by modified method for plant alkaloid extraction. The in vitro anti-staphylococcal 
potential of the alkaloid bioactive fraction was assessed by using micro broth dilution 
and plate count assay methods. Pus and wound isolates had MIC
50
 of 80 μg/mL and 
IC
50
 of 27.22 μg/mL respectively. Burn isolates showed MIC
50
 of 320 μg/mL and 
13.57 μg/mL respectively. Urine and vaginal isolates exhibited a MIC
50
 of 80 μg/mL 
and IC
50 
of 13.15 μg/mL respectively. Cefixime had MIC
50
 values was 320 μg/mL, 160 
μg/mL and 160 μg/mL for pus and wound, burn, urine and vaginal isolates indicating 
the refractory behaviour when compared to alkaloid bioactive fraction from the leaves 
of Callistemon. The alkaloid bioactive fraction exhibits immense activity compared 
to standard antibiotic Cefixime. This work is the first report of alkaloids and their 
antimicrobial activity from Callistemon rigidus leaves. The results suggest further 
isolation of individual alkaloids from alkaloid bioactive fraction and assessment their 
anti-staphylococcal activity as leads for development of anti-staphylococcal drugs.
Key Words: Callistemon rigidus, Staphylococcus aureus, MIC50, alkaloid bioactive 
fraction, Cefixime.
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1 INTRODUCTION
Multidrug resistant Staphylococcus aureus has created a critical situation for the clinicians due to their refractory behaviour against the current armamentarium of antimicrobials. Methicillin resistant 
Staphylococcus aureus (MRSA) infections complicate the therapy in the 
immunocompromised, the elderly, the infants and patients in surgical and burn 
units (Saxena and Gomber, 2010). Hence there is a need to develop therapeutic 
alternatives to overcome the refractory behaviour in treating chronic infections 
caused by these multidrug resistant pathogenic microbes. Plant extracts possess 
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a variety of specialized chemicals and biochemicals as a response to various 
environmental stresses like competition for nutrients, space, allelopathic 
interactions and pathogenesis (Saxena and Kumar, 2000). These specialized 
chemicals and biochemicals are largely underexplored and possess anti-
microbial properties which may be directly or indirectly used in development 
of new drugs to overcome the multidrug resistant pathogenic microbes. 
We have earlier reported the potential antimicrobial activity of crude leaf 
extract of Callistemon rigidus R.Br. (Myrtaceae) against multidrug resistant 
Staphylococcus aureus; ESBL (extended spectrum of β-lactamase) producing 
E. coli and multidrug resistant Pseudomonas species (Saxena and Gomber, 
2006; Gomber and Saxena; 2007; Gomber and Saxena, 2010). 
Phytochemical investigations previously have revealed aromatic nature of 
the plant owing to the higher content of α-pinene, 1, 8-cineol and α-terpineol 
(Jirovitz et al., 1997). The crude leaf extract possesses higher concentration 
of alkaloids whose antimicrobial properties have not been reported in the 
literature so far. In the present study we report the isolation of alkaloids from 
leaves of Callistemon rigidus and their assessment for anti-staphylococcal 
potential using a test panel of reference and clinical isolates.
2 MATERIALS AND METHODS
2.1 Leaf Collection 
Fresh and healthy leaves (no visible contamination) of Callistemon rigidus 
were collected in month of October from the Thapar University campus by 
Ms. Charu Gomber and confirmed with the herbarium sample deposited at the 
Department of Biotechnology and Environmental Sciences, numbered as #7 
San 03. Samples were thoroughly washed under running water and air-dried. 
The fresh weight was noted, and the samples were subjected to drying at 37°C 
and pulverised into a fine powder. 
2.2 Isolation of crude alkaloid extracts 
Microwave assisted extraction was employed for direct extraction of the 
alkaloids from the dried pulverized leaves of Callistemon rigidus by cellular 
destruction initially and then steeping with 5% acetic acid at 120 rpm, 28 °C 
for 2 h. The insoluble material was removed by filtration and the aqueous phase 




) so as to remove chlorophylls 
followed by extraction with ethyl acetate for removal of fats. The aqueous phase 
was further taken up for basification with sodium carbonate as it exhibited 
the antimicrobial activity. It was re-extracted with dichloromethane to obtain 
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Dried and finely ground leaf (powder form)





Dipped in 5% Acetic Acid (1:10). kept for extraction at 120rpm, 28˚C for 2 hrs
Filtered to obtain aqueous solution
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Figure 1: Schematic representation of extraction of Alkaloid Bioactive Fraction 
from C. rigidus leaves
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organic and aqueous fractions which were tested for antimicrobial activity 
(Hadi and Bremner, 2001) (Fig.1). Subsequently phytochemical tests using 
Dragendroff’s, Mayer’s and Marquis Reagents were carried out to confirm the 
presence of alkaloids.
2.3 Evaluation of antimicrobial activity of crude Alkaloid Bioactive 
Fraction (ABF)
The bioactivity of the crude alkaloid bioactive fraction was evaluated by in 
vitro microbroth dilution method using 96-well microtitre plate and plate 
count assay.
2.3.1 Test Panel of Microorganisms 
The test panel comprised of reference and clinical isolates of Staphylococcus 
aureus. The resistance patterns of these isolates have been predetermined and have 
been grouped as VRSA, VISA, MRSA and MARSA (Table 1). The maintenance 
medium of these cultures was Trypticase Soya Agar and these were activated on 
cation adjusted Mueller Hinton (MH) broth 18- 24 h prior to the test.
2.3.2 In vitro microbroth dilution assay 
The in vitro microbroth dilution assay using 96 well microtitre plate and 3-(4, 
5-dimethyl-2-thiazolyl - 5-Diphenyl-2H)-tetrazolium bromide (MTT) assay 
was performed to establish to MIC and MIC
50
 of the alkaloid bioactive fraction 
(O’ Shea et al., 2009). Since visual MIC of each organism varies in the test 
panel of microorganisms being tested, MIC
50 
is the term used for the minimum 
MIC which is inhibiting 50% of the microbes in the test panel. The alkaloid 
bioactive fraction (ABF) was evaluated between 640-10 μg/mL. 50 μl of the 
bacterial suspension in saline was added to 125 μl of MH broth to achieve a 
final bacterial cell concentration of 105 cells in the test and control wells on the 
titre plate. Subsequently the plates were incubated for 2.5 hours at 37°C after 
which 25 μl of the test extract at different concentrations was added. These 
were then incubated for 24 hours at 37°C. After 24 hours 20 μl of 0.02% MTT 
was added to each well. The MIC value was taken as the lowest concentration 
of the ABF where no colour change occurred. The assay was performed in 
triplicates. Cefixime served as a positive control. 
2.3.3 Plate count assay
The surface plate count assay was used to estimate the viable counts of the test 
panel bacteria at MIC concentration of ABF (Miles and Mishra, 1938; Slack 
and Wheldon, 1978). Briefly 10 μl aliquots were withdrawn using a sterile tip 









Journal of Pharmaceutical Technology, Research and Management (JPTRM), Volume 1, May 2013
Table 1. Test panel isolates of Staphylococcus aureus 
Species Culture Id Repository Resistance pattern
Pus and Wound Isolates
Staphylococcus aureus Sau A1 AIIMS* MRSA
Staphylococcus aureus Sau A2 AIIMS MRSA
Staphylococcus aureus Sau A4 AIIMS ----
Staphylococcus aureus Sau G1 GMCP VISA (MIC= 16μg/ ml)+
Staphylococcus aureus Sau G2 GMCP MRSA, MARSA
Staphylococcus aureus Sau G3 GMCP MARSA
Staphylococcus aureus Sau G10 GMCP MRSA, MARSA
Staphylococcus aureus Sau G14 GMCP MARSA
Staphylococcus aureus Sau G23 GMCP MARSA
Staphylococcus aureus Sau G24 GMCP MARSA
Staphylococcus aureus Sau G25 GMCP MARSA
Staphylococcus aureus Sau G27 GMCP MARSA
Staphylococcus aureus Sau G28 GMCP MARSA
Burn Isolates
Staphylococcus aureus Sau G9 GMCP MRSA
Staphylococcus aureus Sau G15 GMCP MARSA
Staphylococcus aureus Sau G16 GMCP MRSA
Staphylococcus aureus Sau G17 GMCP VISA (MIC= 16μg/ ml)
Staphylococcus aureus Sau G18 GMCP MRSA, MARSA
Staphylococcus aureus Sau G19 GMCP MRSA, MARSA
Staphylococcus aureus Sau G 26 GMCP MRSA
Urine and Vaginal Isolates
Staphylococcus aureus Sau A3 GMCP ----
Staphylococcus aureus Sau G4 GMCP MRSA, MARSA
Staphylococcus aureus Sau G5 GMCP MARSA
Staphylococcus aureus Sau G7 GMCP VISA (MIC= 16μg/ ml), MARSA
Staphylococcus aureus Sau G11 GMCP MRSA, MARSA
Staphylococcus aureus Sau G13 GMCP
Standard Culture
Staphylococcus aureus Sau NCTC LHMC Antibiotic sensitivity testing strain
*AIIMS: All India Institute of Medical Sciences, New Delhi, INDIA; GMCP: Government Medical College, Patiala, 
INDIA, LHMC: Lady Harding Medical College, New Delhi, INDIA. 
+VISA (Vancomycin Intermediate S. aureus); VRSA (Vancomycin resistant S. aureus), 
MRSA (Methicillin resistant S. aureus); MARSA (Multi- antibiotic resistant S. aureus)
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Table 2. Minimal Inhibitory Concentration (MIC) of ABF against test isolates 
by in vitro microbroth dilution assay.
Test Isolate 
Groups
Average Values Culture Id MIC ( µg/
ml) of ABF 
MIC( µg/ml) 
of Cefexime 











Sau A1 320 40
Sau A2 640 160
Sau A4 10 80
Sau G1 320 320
Sau G2 80 320
Sau G3 80 320
Sau G10 160 320
Sau G14 80 320
Sau G23 80 80
Sau G24 640 160
Sau G25 160 80
Sau G27 80 160
Sau G28 80 160
Burn Isolates MIC 
ABF 








Sau G9 640 320
Sau G15 160 160
Sau G16 320 160
Sau G17 320 40
Sau G18 320 80
Sau G19 20 40
Sau G26 160 160












Sau A3 640 160
Sau G4 80 80
Sau G5 80 80
Sau G7 80 160
Sau G11 320 160
Sau G13 80 320







Sau NCTC 80 80
All the values are means of triplicate readings
a-Non-significant difference in mean MIC values of ABF and Cefixime by unpaired t-test
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micropipette from the test samples containing MIC concentrations of ABF at 
different time intervals viz. 2, 4, 6, 8, 10, 22, 24 h from the 96-well titre plates 
and placed as a single drop on MH agar plates divided into number of sectors 
and observed for the growth of the bacteria as pinhead colonies without the 
presence of any confluence after incubation of 12-18 h at 37 °C.
2.4 Statistical analysis
All the data presented in the tables and figures are Mean ± SD values of 
triplicate readings. Further Graph pad Prism ver. 5.1 has been used to assess 
the difference in IC
50
 values in different groups of test microbe’s viz. pus-
wound, burn and urine-vaginal isolates by one way ANOVA and Bonferroni’s 
multiple comparison test. 
3 RESULTS
The minimal inhibitory concentration (MIC) of ABF as observed by in vitro 
micro broth dilution assay using visual method using MTT ranged between 
10-640 μg/mL for Pus and wound isolates. The MIC
50
 of these isolates was 80 
μg/mL. Burn isolates exhibited a MIC range of 20-640 μg/mL with a MIC
50
 
of 320 μg / mL. Vaginal and Urine isolates exhibited MIC range of 80-640 μg/
mL with MIC
50
 of 80μg/mL. The MIC for the reference strain was 80 μg/mL. 
The positive control Cefexime exhibited a MIC in the range of 40-320 μg/mL 
(Table 2). A non-significant difference between average MIC values of ABF 
and Cefixime was observed in different groups of test isolates.
The viable count reduction by plate assay indicated that at MIC 
concentrations the ABF induced a bactericidal action in SauA4 and SauG2. 
Bacteriostatic activity of ABF at MIC concentration was exhibited by SauG3 
and SauG10. Rest pus and wound isolates exhibited a reduction in viable count 
when compared to the control (Fig 2). 
Among the burn isolates both Sau G15 and Sau G17 exhibited reduction 
in viable counts by 1 log at MIC concentration of the ABF when compared to 
initial inoculums count indicating a bactericidal action (Fig.3). 
Sau G7 and Sau G11 were the only among urine and vaginal isolates 
exhibiting bactericidal activity at MIC concentrations of ABF. There was 2-log 
and 3-log reduction in the viable count in Sau G7 and Sau G11 respectively 
when compared to the initial inoculum count (Fig.4) 
IC
50
 range of ABF for pus and wound isolates was between 3.422-189.9 μg/
ml. Sau A4 exhibited the least IC
50
 of 3.42 μg/ml. The burn isolates exhibited 
IC
50
 in range of 6.413- 80.9 μg/ml. Sau G16 exhibited the least IC
50
 of 6.4 μg/
ml. The urine and vaginal isolates were having an IC
50
 in the range of 4.21-
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Figure 2: Kill pattern of pus and wound isolates by alkaloid bioactive fraction 
at MIC
Figure 3: Kill pattern of burn isolates by alkaloid bioactive fraction at MIC
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Figure 4: Kill pattern of urine and vaginal isolates by bioactive alkaloid fraction 
at MIC 
74.5 μg/ml. Sau G4 exhibited the least IC
50
 value among the Urine and vaginal 
isolates (Table 3). 
A non-significant difference was found in the average IC
50
 values of 
pus-wound, burn and urine-vaginal isolates by one way ANOVA at p<0.05. 
Similarly Bonferroni’s multiple comparison tests also indicated a non-
significant difference in the three groups of test isolates. 
4 DISCUSSION
Plant alkaloids are known to possess anti-cancer and anti-bacterial activities. 
Alkaloid rich fractions from leaves of Prosopis julifora exhibited a MIC of 
50 μg/ml against Staphylococcus aureus (Singh et al., 2011). Alkaloid extract 
from stem bark of Mahonia manipurensis exhibited an antibacterial activity 
against Bacillus cereus and Enterococcus faecalis however Staphylococcus 
aureus was not tested by them (Pfoze et al., 2011). Garba and Okeniyi (2012) 
have evaluated the total alkaloid extracts from Jatropha curcas, Calotropis 
procera, Mangifera indica, Carica papaya and Psidium guajava and found 
that the possessed a broad spectrum antibacterial activity. All the alkaloids 
from leaves of Elaeagnus mollis had obvious anti-microbial effect on Bacillus 
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Table 3: IC
50
 values of ABF against test panel staphylococcal groups.
Test Isolate Groups Mean* IC50 Values (µg/
ml)
Culture Id ∗∗IC50 ± SD of 
ABF ( µg/ml)
Pus and Wound Isolates IC 
50 
= 27.22 ± 2.86
 
Sau A1 7.24 ± 2.5
Sau A2 3.82 ± 1.9
Sau A4 3.42 ± 1.71
Sau G1 189.9 ± 4.46
Sau G2 20.49 ± 1.94
Sau G3 46.7 ± 6.6
Sau G10 96.8 ± 2.63
Sau G14 12 ± 1.6
Sau G23 42.7 ± 1.7
Sau G24 122 ± 5.24
Sau G25 41.68 ± 1.41
Sau G27 6.89 ± 4.67
Sau G28 151.1 ± 3.55
Burn Isolates IC 
50 
= 13.57 ± 2.48 Sau G9 68.9 ± 2.14
Sau G15 12.03 ± 2
Sau G16 6.4 ± 3.4
Sau G17 20.4 ± 1.4
Sau G18 10.71 ± 7
Sau G19 9.1 ± 2.3
Sau G26 80.9 ± 1.8
Urine and Vaginal Isolates IC 
50 
= 13.12 ± 2.45 Sau A3 20.3 ± 145
Sau G4 4.21 ± 1.86
Sau G5 74.5 ± 6.92
Sau G7 10.3 ± 3.72
Sau G11 4.25 ± 2.14
Sau G13 18.3 ± 1.48
Standard Culture IC 
50 
= 30.9 ± 1.3 Sau NCTC 30.9 ± 1.3
∗   Geometric means
∗∗   All values are means of triplicate readings
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subtilis, Staphylococcus aureus, V. ceratosperma and Verticillium dahliae. 
The MIC of these alkaloids against Bacillus subtilis and Staphylococcus 
aureus was 40 μg/ml and 80 μg/ml respectively (JiaMing et al., 2010). Total 
alkaloid fraction of Halorrhena floribunda stem bark extracts by in vitro 
microbroth dilution assay was 96.25 ± 36.25 μg/ml. The IC
50
 value was 46.3 
± 14.7 μg/ml using test panel of Bacillus sp (Patrice et al., 2007). Alkaloid 
from Sida acuta leaves exhibit potential antibacterial activity in the range 
of 16 - 400 μg/ml (Karou et al., 2005). Our results also exhibit a potential 
activity of the alkaloid bioactive fraction from Callistemon rigidus with 
MIC
50
 ranging between 80-320 μg/ml and IC
50
 values ranging between 3.422-
189.9 μg/ml. The presence of alkaloids possessing anti-bacterial activity 
in Callistemon rigidus is being reported for the very first time. Further 
separation of individual alkaloids from the alkaloid bioactive fraction and 
their assessment against the same test panel of clinical, multidrug resistant 
Staphylococci would help in finding out relevant alkaloids which could 
be developed into drugs. Further synergistic activities of these alkaloids 
would also be helpful in developing formulations in development personal 
care and hygiene products to prevent transmission of Staphylococcus in the 
community and hospital settings. 
5 CONCLUSION
The alkaloid bioactive fraction from Callistemon rigidus was as efficient as 




 values against the test panel isolates. The 
ABF was having potential anti-Staphylococcal activity and was efficacious 
as Cefixime which is a pure antimicrobial. Hence further separation of 





than currently observed to overcome the refractory strains of Staphylococcus 
aureus.
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